Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220
≥99.2% Lot SL-2026-152
Retatrutide 10 mg — ≥99.2% analytical research vial
≥99.2%
Analytical Purity
24–48h Dispatch
CH/EU Cold-Chain
SL-2026-152
Active Batch Lot
Metabolic & Incretin Research • In stock — Ready to ship

Retatrutide (10 mg)

€92 10 mg • EUR

Retatrutide (LY3437943) is a 39-amino acid acylated triple incretin receptor agonist targeting GIPR, GLP-1R, and GCGR with balanced receptor potency, widely investigated in energy-expenditure and metabolic-flux research.

Chemical & Registry Specifications
CAS Registry Number 2381089-83-2
Molecular Formula C221H342N46O68
Molecular Weight 4731.33 g/mol
Counterion / Form Acetate lyophilized salt
Sequence / Structural Class 39-aa acylated triple-agonist polypeptide (Aib2, α-Me-Leu13, Aib20, C20 fatty diacid at Lys17)
Primary Biological Target / Pathway Triple GIP Receptor (GIPR), GLP-1R & Glucagon Receptor (GCGR) Agonist
Cold-chain dispatch: CH 1–2d (Free) • EU 2–4d (€12, Free >€150) Shipping & returns
Min. order €220.00 • Payment via SEPA Bank Transfer (EUR) (request IBAN via LiveChat/email) or Crypto (BTC, ETH, USDT, USDC, SOL, XMR).

Scientific Profile & Research Key Points: Retatrutide

Retatrutide (LY3437943) is a 39-amino acid acylated triple incretin receptor agonist targeting GIPR, GLP-1R, and GCGR with balanced receptor potency, widely investigated in energy-expenditure and metabolic-flux research.

Full 39-aa C20-acylated sequence confirmed (4731.33 Da)
Triple GIPR / GLP-1R / GCGR receptor signaling profile
Cold-chain dispatched at ≥99.2% RP-HPLC purity
Primary Literature Reference Coskun T. et al., Cell Metab (2022) — LY3437943 (Retatrutide) triple GIP/GLP-1/glucagon receptor pharmacology (PMID: 35985340)
View on PubMed ↗

Active Batch Release Specifications (Lot SL-2026-152)

Analytical release verification for current Retatrutide (10 mg) inventory

Open Full Batch Registry
Batch Lot # Release Date Analytical Method Purity Spec Endotoxin (LAL) Moisture
SL-2026-152 2026-10-28 RP-HPLC (C18, 214nm) + ESI-MS ≥99.2% (Single Peak) <0.5 EU/mg <2.8% (Karl Fischer)

Laboratory Solubilization & Storage Protocol

Recommended Solvent / Handling

Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4); swirl gently

Temperature & Stability

Store lyophilized at -20°C; refrigerate reconstituted solution at 2°C–8°C (never freeze solution).

Retatrutide — Technical Questions & Answers

What is the molar concentration when reconstituting Retatrutide (10 mg) in 2.0 mL?

Reconstituting the full 10 mg vial of Retatrutide (MW 4731.33 g/mol) in 2.0 mL of diluent produces a 5.00 mg/mL stock solution — equivalent to approximately 1.06 mM (1,057 µM) gross molarity before Net Peptide Content (NPC) adjustment.

How does Retatrutide's counterion stoichiometry affect assay mass calculations?

Retatrutide (CAS 2381089-83-2, formula C221H342N46O68) is supplied as Acetate lyophilized salt. Because counterions and residual bound water contribute to gross lyophilized weight, quantitative receptor-binding assays should apply batch Net Peptide Content (NPC) or active-ion correction rather than gross cake weight alone.

Which analytical methods verify Retatrutide Lot SL-2026-152 and what pathway does it target?

Lot SL-2026-152 undergoes RP-HPLC (C18, 214nm) + ESI-MS confirming ≥99.2% (Single Peak) and identity against 4731.33 g/mol. In preclinical literature, Retatrutide targets Triple GIP Receptor (GIPR), GLP-1R & Glucagon Receptor (GCGR) Agonist (Coskun T. et al., Cell Metab (2022) — LY3437943 (Retatrutide) triple GIP/GLP-1/glucagon receptor pharmacology (PMID: 35985340)).

Research Use Only (RUO): Retatrutide is supplied strictly for laboratory in-vitro experimentation and analytical investigation by qualified personnel. Not for human or veterinary administration.

Related Scientific Monographs

Peer-reviewed mechanism summaries and analytical protocols

All monographs (44)

Related Metabolic & Incretin Research Compounds

View category →
≥99.0%
5-Amino-1MQ 10 mg — ≥99.0% Research Vial
5-Amino-1MQ
10 mg In stock
CAS 42464-96-0
MW: 286.11 g/mol
€58
≥99.0%
Adipotide 5 mg — ≥99.0% Research Vial
Adipotide
5 mg In stock
CAS 859216-15-2
MW: 2555.20 g/mol
€55
≥99.0%
AICAR 50 mg — ≥99.0% Research Vial
AICAR
50 mg In stock
CAS 2627-69-2
MW: 258.23 g/mol
€48
≥99.0%
AOD-9604 5 mg — ≥99.0% Research Vial
AOD-9604
5 mg In stock
CAS 221231-10-3
MW: 1815.08 g/mol
€44

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog